A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....